Learn About Abdominal Obesity Metabolic Syndrome

What is the definition of Abdominal Obesity Metabolic Syndrome?
Abdominal obesity metabolic syndrome is a disease that is influenced by both genetic and environmental factors characterized by a clustering of insulin resistance, high levels of insulin, abnormal blood fats (lipids), high blood pressure, abdominal obesity, glucose intolerance or non-insulin dependent diabetes mellitus, and an increased risk of adverse cardiovascular events. There are different types of abdominal obesity metabolic syndrome, such as abdominal obesity metabolic syndrome 1 or 4. Factors that influence the development of abdominal obesity metabolic syndrome include age, smoking, alcohol, diet, and physical inactivity. Abdominal obesity metabolic syndrome occurs most often in Mexican American women.
Save information for later
Sign Up
What are the symptoms of Abdominal Obesity Metabolic Syndrome?
Symptoms of abdominal obesity metabolic syndrome may include chest pain; radiating pain in chest, jaw, or down left arm (angina pectoris); swelling; abdominal obesity; high blood pressure; high blood triglycerides and low high-density lipoprotein levels; high fasting glucose levels; type 2 diabetes; coronary heart disease (plaque build-up in arteries; CHD); heart attack; and cardiac death.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Abdominal Obesity Metabolic Syndrome?
Treatment for abdominal obesity metabolic syndrome focuses first on lifestyle changes, such as weight loss, exercise, healthy diet, and quitting smoking. Medications for treating abdominal obesity metabolic syndrome may include diabetes drugs; statins to lower blood lipids (fats), such as atorvastatin; blood pressure medications; and blood-thinning medications, such as aspirin or clopidogrel to prevent blood clots.
Who are the top Abdominal Obesity Metabolic Syndrome Local Doctors?
TK
Tomoyuki Kawada
Elite
Highly rated in
41
conditions

Nippon Medical School

Tokyo, JP 

Tomoyuki Kawada is in Tokyo, Japan. Kawada is rated as an Elite expert by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. They are also highly rated in 41 other conditions, according to our data. Their top areas of expertise are Abdominal Obesity Metabolic Syndrome, Metabolic Syndrome, Obstructive Sleep Apnea, and Maturity Onset Diabetes of the Young.

View Profile
RR
Ricardo M. Rodriguez-Mora
Elite
Highly rated in
3
conditions

University Of Castilla La Mancha

Sport Sciences 
Toledo, CM, ES 

Ricardo Rodriguez-Mora is in Toledo, Spain. Rodriguez-Mora is rated as an Elite expert by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. He is also highly rated in 3 other conditions, according to our data. His top areas of expertise are Abdominal Obesity Metabolic Syndrome, Metabolic Syndrome, Dehydration, and Obesity.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
RK
Roya Kelishadi
Elite
Highly rated in
19
conditions

Child Growth And Development Research Center, Research Institute For Primordial Prevention Of Non Communicable Disease, Isfahan University Of Medical Sciences

Tehran, IR 14176

Roya Kelishadi is in Tehran, Islamic Republic of Iran. Kelishadi is rated as an Elite expert by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. She is also highly rated in 19 other conditions, according to our data. Her top areas of expertise are Congenital Hyperinsulinism, Obesity in Children, Metabolic Syndrome, and Obesity.

View Profile
View All Doctors
What are the latest Abdominal Obesity Metabolic Syndrome Clinical Trials?
Study of Metabolic Syndrome in Patients Undergoing Endovascular Aortic Repair (EVAR)
Status: Not yet recruiting
Start Date: June 1, 2020
Intervention Type: Other
View Trial
Summary: This prospective study aims to identify the prevalence of metabolic syndrome in patients undergoing EVAR and the implications of metabolic syndrome on the postoperative outcome, the major complications, the thromboembolic events and the perioperative mortality and morbidity of the patients undergoing vascular surgery.
Match to trials
Find the right clinical trials for you in under a minute
Get started
Effects of Gum Arabic Supplementation on the Components of Metabolic Syndrome Among Post Menopausal Females in Khartoum State 2019
Who is this study for: Post menopausal females
Status: Active, not recruiting
Start Date: December 4, 2019
Intervention Type: Drug
Phase: Phase 2
View Trial
Summary: Gum Arabic ingestion has been proved to decrease some of the inflammatory markers in some metabolic diseases that have an inflammatory background. Nevertheless, the mechanism/s by which it does so is uncertain. This study is targeting one of the postulated molecular mechanisms at genetic level that may help to understand how Gum Arabic exerts its effect .The effects of GA on Nuclear Factor Kappa B...
View All Clinical Trials
What are the Latest Advances for Abdominal Obesity Metabolic Syndrome?
Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
Condition: Metabolic Syndrome
Journal: Pharmacological research
Treatment Used: Synbiotic Supplementation
Number of Patients: 1049
Published: January 09, 2022
View publication
Summary: Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
Antioxidant-Rich Dietary Intervention Improves Cardiometabolic Profiles and Arterial Stiffness in Elderly Koreans with Metabolic Syndrome.
Condition: Elderly Koreans with Metabolic Syndrome
Journal: Yonsei medical journal
Treatment Used: Antioxidant-Rich Dietary Intervention
Number of Patients: 31
Published: December 16, 2021
View publication
Summary: Antioxidant-Rich Dietary Intervention Improves Cardiometabolic Profiles and Arterial Stiffness in Elderly Koreans with Metabolic Syndrome.
Tired of the same old research?
Check Latest Advances
Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants.
Condition: Metabolic Syndrome
Journal: Clinical nutrition (Edinburgh, Scotland)
Treatment Used: Blueberry Anthocyanin
Number of Patients: 45
Published: December 09, 2021
View publication
Summary: Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants.
View All Latest Advances